Pirenzepine
From Wikipedia, the free encyclopedia
 |
This needs additional citations for verification. Please help improve this article by adding reliable references. Unsourced material may be challenged and removed. (June 2006) |
 |
|
|
Pirenzepine
|
|
| Systematic (IUPAC) name | |
| 11-[(4-Methylpiperazin-1yl)acetyl]6,11-dihydro-5H-pyrido[2,3-b][1,4]benzodiazepin-6-on | |
| Identifiers | |
| CAS number | |
| ATC code | A02 |
| PubChem | |
| DrugBank | |
| Chemical data | |
| Formula | C19H21N5O2 |
| Mol. mass | 351.403 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
Pirenzepine (marketed by Merck Marker under the trade-name Gastrozepin) is used in the treatment of peptic ulcers, as it reduces gastric acid secretion and reduces muscle spasm. It is in a class of drugs known as Muscarinic receptor antagonists - acetylcholine being the neurotransmitter of the parasympathetic nervous system which initiates the rest-and-digest state (as opposed to fight-or-flight), the result being an increase in gastric motility and digestion. It has no effects on the brain and spinal cord as it cannot diffuse through the blood-brain barrier.
Pirenzepine has been investigated for use in myopia control.[1]
[edit] References
- ^ Czepita D (2005). "Fundamentals of modern treatment of myopia". Ann Acad Med Stetin 51 (2): 5–9. PMID 16519089.
 |
This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
|
||||||||||||||
